BIOTEST AG/ DE0005227201 /
| 22/06/2023 12:27:18 | Chg. -0.10 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 42.60EUR | -0.23% | 26 Turnover: 1,107.60 |
-Bid Size: - | -Ask Size: - | 2.43 bill.EUR | - | 12.81 |
Fundamentals
| FY 2024 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | - EUR | - |
| EPS Diluted: | - EUR | - |
| Revenues per Share: | - EUR | - |
| Book Value per Share: | - EUR | - |
| Cash Flow per Share: | - EUR | - |
| Dividend per Share: | - EUR | - |
| Total | Units_-_Short | |
| Revenues: | - EUR | - |
| Net Income: | - EUR | - |
| Operating Cash Flow: | - EUR | - |
| Cash and Cash Equivalents: | - EUR | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 12.81 | - |
| P/S Ratio: | 2.37 | - |
| P/BV ratio: | 3.25 | - |
| P/CF Ratio: | -600.90 | - |
| PEG: | - | - |
| Earnings Yield: | 7.80% | - |
| Dividend Yield: | - | - |
| Market Capitalization | ||
| Market Capitalization: | 2.43 bill. EUR | - EUR |
| Free Float Market Cap.: | - EUR | - EUR |
| Market Cap. / Employee: | 668,767.3256 EUR | - EUR |
| Shares Outstanding: | 39.57 mill. | |
Profitability
| Gross Profit Margin: | - |
| EBIT Margin: | - |
| Net Profit Margin: | - |
| Return on Equity: | - |
| Return on Assets: | - |
Financial Strength
| Liquidity I / Cash Ratio: | - |
| Liquidity II / Quick Ratio: | - |
| Liquidity III / Current Ratio: | - |
| Debt / Equity Ratio: | - |
| Dynam. Debt / Equity Ratio: | - |
Efficiency
| Employees: | - |
| Personal Expenses / Employee: | - EUR |
| Revenues / Employee: | - EUR |
| Net Income / Employee: | - EUR |
| Total Assets / Employee: | - EUR |
| * Fiscal Year End: | - |
| Accounting Standard: | - |
| Currency: | EUR |
